Skip to main content
Mark Schattner, MD, Gastroenterology, New York, NY, Memorial Sloan Kettering Cancer Center

MarkASchattnerMD

Gastroenterology New York, NY

Advanced Endoscopic Interventional

Associate Professor, Medicine, Weill Cornell Medical College

Dr. Schattner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schattner's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Gastroenterology, 1999 - 2002
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1996 - 2026
  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Tu1435 ENDOSCOPIC BILIARY STENTING FOR MALIGNANT BILIARY OBSTRUCTION IS TECHNICALLY SUCCESSFUL IN PATIENTS WITH PRE- EXISTING DUODENAL STENTSMay 2018
  • Tu1435 ENDOSCOPIC BILIARY STENTING FOR MALIGNANT BILIARY OBSTRUCTION IS TECHNICALLY SUCCESSFUL IN PATIENTS WITH PRE- EXISTING DUODENAL STENTSMay 2018
  • Predictors of Clinical Outcome of Colonic Stents in Patients with Malignant Large-Bowel Obstruction Due to Extracolonic MalignancyJanuary 2018

Press Mentions

  • Treatment of Esophageal/Gastroesophageal Junction Adenocarcinoma in Patients with History of Prior Bariatric Surgery
    Treatment of Esophageal/Gastroesophageal Junction Adenocarcinoma in Patients with History of Prior Bariatric SurgeryMay 7th, 2023

Hospital Affiliations